Prota Therapeutics Announces Publication in Allergy of Long-Term Peanut Allergy Study Confirming Clinical Remission as the Optimal Treatment Outcome

Results affirm the advantages of Prota’s remission peanut OIT treatments, which lead to significant and sustained benefits including substantially improved Health Related Quality of Life Study underscores the need to aim for remission as the optimal treatment outcome. Highlights…